Novo Nordisk Sues Eli Lilly Over GLP-1 Drug Advertising Claims

Novo Nordisk has filed a federal lawsuit against Eli Lilly over advertising claims for its GLP-1 drugs, alleging misleading comparisons and outdated data. The case focuses on ads that compare lower doses of Novo's Wegovy with higher doses of Lilly’s Zepbound and Mounjaro.

By Proactive Tue, July 21, 2026 at 6:18 PM GMT+3 2 min read · Yahoo Finance · July 21, 2026, 15:18 UTC

Novo Nordisk Sues Eli Lilly Over GLP-1 Drug Advertising Claims

Tickers: $LLY $NVO

Topics: advertising claims GLP-1 drugs pharmaceutical

Read the full article at Yahoo Finance

More Politics news

Pomerantz Law Firm Investigates HCA Healthcare Following Reduced Profit Guidance PR Newswire · November 12, 2026, 16:25 UTC
Pomerantz Law Firm Investigates Greenland Energy (GLND) Following Short Seller Report PR Newswire · November 12, 2026, 16:15 UTC
Pomerantz Law Firm Investigates Potential Securities Fraud at Foghorn Therapeutics (FHTX) PR Newswire · November 12, 2026, 16:00 UTC
Pomerantz Law Firm Investigates VinFast Auto Ltd. Following Significant Operating Losses PR Newswire · November 12, 2026, 15:55 UTC
Class Action Lawsuit Filed Against Skechers U.S.A., Inc. Regarding Take-Private Acquisition PR Newswire · November 12, 2026, 15:00 UTC
Class Action Lawsuit Filed Against Compass, Inc. Regarding Merger Disclosures PR Newswire · November 12, 2026, 15:00 UTC
Scott Colom Defeats Incumbent Cindy Hyde-Smith in Mississippi Senate Election CNBC · November 11, 2026, 23:03 UTC
Advocacy Groups Prepare to Pressure Politicians Over Data Center Restrictions Following Midterm Elections The Verge · November 11, 2026, 21:56 UTC
Alleged Security Concerns Involving Nvidia CEO Jensen Huang Prompt US-Taiwan Official Concern The Verge · November 11, 2026, 19:22 UTC
Scott Colom Maintains Narrow Lead Over Cindy Hyde-Smith in Mississippi Senate Race CNBC · November 10, 2026, 21:55 UTC